Microbot Medical Inc.
    SEC Filings

    |
    |

    All SEC filings by Microbot Medical Inc. (MBOT) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.

    Financials

    10-QQuarterly reportView DiffAug 11, 2026
    10-QQuarterly reportView DiffMay 13, 2026
    10-KAnnual reportView DiffMar 26, 2026
    10-QQuarterly reportView DiffNov 12, 2025
    10-QQuarterly reportView DiffAug 12, 2025
    10-QQuarterly reportView DiffMay 14, 2025
    ARSAnnual report to shareholdersApr 29, 2025
    10-KAnnual reportView DiffMar 25, 2025
    10-QQuarterly reportView DiffNov 13, 2024
    ARSAnnual report to shareholdersNov 6, 2024

    Events

    8-KFiles 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second QuarterAug 11, 2026
    8-KCurrent reportAug 7, 2026
    8-KAmong Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual MeetingJul 21, 2026
    8-KReports Over 100% Revenue and Customer Growthas Procedure Volume Also Rises in the Second Quarter of 2026Jul 7, 2026
    8-KCurrent reportJun 30, 2026
    8-KCurrent reportJun 25, 2026
    8-KCurrent reportJun 23, 2026
    8-KCurrent reportJun 16, 2026
    8-KCurrent reportJun 9, 2026
    8-KCurrent reportJun 2, 2026

    Registrations and Prospectuses

    424B5Prospectus supplement for primary offeringApr 10, 2026
    424B3Prospectus supplementNov 19, 2025
    424B3Prospectus supplementNov 19, 2025
    S-3/AShelf registrationView DiffOct 28, 2025
    S-3/AShelf registrationView DiffOct 28, 2025
    S-3Shelf registrationView DiffOct 14, 2025
    S-3Shelf registrationView DiffOct 14, 2025
    D$25.24 Mm in Options, Sold $25.24 Mm, 1 InvestorSep 29, 2025
    S-8Registration of securities for employeesJul 22, 2025
    424B3Prospectus supplementApr 8, 2025

    Proxies

    DEF 14ADefinitive proxyView DiffApr 29, 2025
    DEFA14AAdditional proxy soliciting materialsApr 29, 2025
    PRE 14APreliminary proxyApr 18, 2025
    DEFA14AAdditional proxy soliciting materialsFeb 28, 2025
    DEF 14ADefinitive proxyView DiffFeb 28, 2025
    PRE 14APreliminary proxyFeb 18, 2025
    DEFA14AAdditional proxy soliciting materialsNov 6, 2024
    DEF 14ADefinitive proxyView DiffNov 6, 2024
    DEFA14AAdditional proxy soliciting materialsSep 19, 2023
    DEF 14ADefinitive proxyView DiffSep 19, 2023

    Other

    EFFECTNotice of effectivenessApr 3, 2025
    EFFECTNotice of effectivenessApr 3, 2025
    EFFECTNotice of effectivenessApr 3, 2025
    EFFECTNotice of effectivenessApr 3, 2025
    EFFECTNotice of effectivenessApr 2, 2025
    CORRESPCorrespondence with SECMar 28, 2025
    UPLOADLetter from SECMar 17, 2025
    EFFECTNotice of effectivenessFeb 14, 2025
    CORRESPCorrespondence with SECFeb 11, 2025
    UPLOADLetter from SECFeb 7, 2025

    Ownership

    4Aileen Ptucha StockburgerApr 3, 2026
    4Martin J. MaddenApr 3, 2026
    4Tal Baruch WenderowApr 3, 2026
    4David James WilsonApr 3, 2026
    4Scott R BurellApr 3, 2026
    4Prattipati LaxminarainApr 3, 2026
    4Harel GadotFeb 20, 2026
    4Juan Diaz-CartelleFeb 20, 2026
    4Simon SharonFeb 20, 2026
    4Rachel VakninFeb 20, 2026